BlackRock Advisors’s UROPLASTY INC-NEW UPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-8,634
Closed -$11K 3825
2015
Q1
$11K Hold
8,634
﹤0.01% 3537
2014
Q4
$18K Hold
8,634
﹤0.01% 3537
2014
Q3
$22K Buy
8,634
+3,049
+55% +$7.96K ﹤0.01% 3486
2014
Q2
$15K Hold
5,585
﹤0.01% 3521
2014
Q1
$20K Buy
5,585
+1,629
+41% +$6.37K ﹤0.01% 3422
2013
Q4
$11K Hold
3,956
﹤0.01% 3503
2013
Q3
$13K Sell
3,956
-868
-18% -$2.43K ﹤0.01% 3416
2013
Q2
$10K Buy
+4,824
New +$11.1K ﹤0.01% 3426

BlackRock Advisors's UPI Position: Q2 2015 in Review

BlackRock Advisors sold out of UROPLASTY INC-NEW (UPI) in Q2 2015, closing a stake of 8,634 shares — an estimated $11K sold.

BlackRock Advisors first reported a position in UPI in Q2 2013 and held it in 8 quarters. The position peaked at $22K in Q3 2014. 0 funds tracked by Wall St. Rank hold UPI as of Q2 2015.

  • BlackRock Advisors reported no remaining UROPLASTY INC-NEW position as of Q2 2015 after selling out during the quarter.
  • BlackRock Advisors sold 8,634 UROPLASTY INC-NEW shares in Q2 2015, an estimated $11K.
  • BlackRock Advisors first reported a position in UROPLASTY INC-NEW in Q2 2013 and held it in 8 quarters.
  • BlackRock Advisors's UROPLASTY INC-NEW position peaked at $22K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q2 2015.

Based on BlackRock Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.